Neglected tropical diseases: progress towards addressing the chronic pandemic

详细信息    查看全文

• 作者：Prof David H Molyneux ; DSc^a ; ^{david.molyneux@lstmed.ac.uk} ; Lorenzo Savioli ; MD^b ; Dirk Engels ; MD^c
• 刊名：The Lancet
• 出版年：2017
• 出版时间：21-27 January 2017
• 年：2017
• 卷：389
• 期：10066
• 页码：312-325
• 全文大小：139 K
• 卷排序：389

文摘

The concept of neglected tropical diseases (NTDs) emerged more than a decade ago and has been recognised as a valid way to categorise diseases that affect the poorest individuals. Substantial progress in control and elimination has been achieved and policy momentum has been generated through continued bilateral, philanthropic, and non-governmental development organisation (NGDO) support, and donations of drugs from pharmaceutical companies. WHO has defined a Roadmap to reach 2020 targets, which was endorsed by member states in a World Health Assembly Resolution in 2013. NTDs have been included within the Sustainable Development Goal targets and are a crucial component of universal health coverage, conceptualised as “leaving no one behind”. WHO reported that more than 1 billion people in 88 countries have benefited from preventive chemotherapy in 2014. The research agenda has defined the need for affordable products (diagnostics, drugs and insecticides). However challenges such as insecurity and weak health systems continue to prevail in the poorest countries, inhibiting progress in scaling up and also in achieving Roadmap goals.